Symbol List Views
Stock Details
CHARTS
COMPANY NEWS
STOCK ANALYSIS
FUNDAMENTALS
HOLDINGS
Edit Symbol List
Symbol Lookup
BPAX: Stock Quote & Summary Data
1.88%
| Last Sale | |
| Change Net / % |
|
| Best Bid / Ask | |
| 1y Target Est: | N/A |
| Today's High / Low | / |
| Share Volume | |
| 50 Day Avg. Daily Volume | 436,681 |
| Previous Close | $ 1.60 |
| 52 Wk High / Low | $ 2.70 / $ 0.81 |
| Shares Outstanding | 27,043,000 |
| Market Value | $ 42,457,510 |
| Annualized Dividend | N/A |
| Ex Dividend Date | N/A |
| Dividend Payment Date | N/A |
| Current Yield | N/A |
| Beta | 1.43 |
| NASDAQ Official Open Price: | $ 1.63 |
| Date of NASDAQ Official Open Price: | Nov. 20, 2009 |
| NASDAQ Official Close Price: | $ 1.57 |
| Date of NASDAQ Official Close Price: | Nov. 20, 2009 |
Intraday Chart |
| 5d | 1m | 6m | 12m | More Charting |
Have a Question About BPAX?
Ask your question about about Biosante Pharmaceuticals, Inc. (BPAX) by typing it in the box below. You'll get direct responses from other members of the NASDAQ Answers community!
Hot Topics in NASDAQ Answers
The most popular questions & answers in the
NASDAQ Answers Community:
Company Description (as filed with the SEC)
We are a biopharmaceutical company that develops hormone therapy products to treat men and women. We also are engaged in the development of our proprietary calcium phosphate nanotechnology, or CaP, primarily for aesthetic medicine, novel vaccines and drug delivery. Our hormone therapy products address a variety of hormone therapies for symptoms that affect both men and women, with an emphasis on women. Symptoms addressed by these hormone therapies in women include sexual dysfunction (hypoactive sexual desire disorder) and hot flashes. The products are gel formulations of testosterone, estradiol and various combinations of testosterone and estradiol. The gels are designed to be quickly absorbed through the skin after application on the upper arm for the women’s products, delivering the hormone to the bloodstream evenly and in a non-invasive, painless manner. ... More ...
Links to all Biosante Pharmaceuticals, Inc. (BPAX) Pages
Stock Analysis
Fundamentals
Holdings/Ownership
Company News for BPAX |
||
|
BioSante Pharmaceuticals to Present at the Lazard Capital Markets Annual Healthcare Conference - Business Wire 11/17/2009 8:00AM |
||
|
BioSante Pharmaceuticals Comments on Boehringer Ingelheim Clinical Test Results in Treatment of Female Sexual Dysfunction - Business Wire 11/16/2009 12:30PM |
||
|
BioSante Pharmaceuticals to Present at Merriman Curhan Ford's Investor Summit - Business Wire 11/10/2009 8:00AM |
||
|
BioSante Pharmaceuticals Reports Third Quarter 2009 Financial Results - Business Wire 11/09/2009 4:25PM |
||
|
BioSante Pharmaceuticals to Present at the Oppenheimer Health Care Conference - Business Wire 10/29/2009 8:00AM |
||
|
BioSante Pharmaceuticals to Present at the Bio Investor Forum - Business Wire 10/22/2009 7:45AM |
||
|
BioSante Pharma Reveals Positive Safety Data In Ongoing LibiGel Phase III Clinical Development Program - RTT News 10/20/2009 10:31AM |
